OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Developments in Human Papillomavirus (HPV) Vaccinology
Anna‐Lise Williamson
Viruses (2023) Vol. 15, Iss. 7, pp. 1440-1440
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Designing of an mRNA vaccine against high-risk human papillomavirus targeting the E6 and E7 oncoproteins exploiting immunoinformatics and dynamic simulation
Md. Mijanur Rahman, Md. Habib Ullah Masum, Rehana Parvin, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0313559-e0313559
Open Access | Times Cited: 3

Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use
Yu Zhang, Ke Qiu, Jianjun Ren, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3

HPV E6/E7: insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor
Peng Qiu, Lujuan Wang, Liang Zuo, et al.
Cancer Gene Therapy (2023) Vol. 31, Iss. 1, pp. 9-17
Closed Access | Times Cited: 29

HPV Infections—Classification, Pathogenesis, and Potential New Therapies
Beata Mlynarczyk-Bonikowska, Lidia Rudnicka
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7616-7616
Open Access | Times Cited: 14

Current status and future directions for the development of human papillomavirus vaccines
Rui Wang, Hongpeng Huang, Chulin Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11

Revolutionizing adjuvant development: harnessing AI for next-generation cancer vaccines
Wei Zhang, Xiaoli Zheng, Paolo Coghi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8

Prophylactic vaccines against HPV-caused cervical cancer: novel vaccines are still demanded
Sogand Amiri, Shiva Rasekh, Seyed Mohammad Iman Moezzi, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1

Vaccine design and development: Exploring the interface with computational biology and AI
Ananya Ananya, Darshan C. Panchariya, Anandakrishnan Karthic, et al.
International Reviews of Immunology (2024) Vol. 43, Iss. 6, pp. 361-380
Closed Access | Times Cited: 7

HPV co‐infections with other pathogens in cancer development: A comprehensive review
Elahe Akbari, Alireza Milani, Masoud Seyedinkhorasani, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 11
Closed Access | Times Cited: 16

HPV vaccination: A key strategy for preventing cervical cancer
Muhammad Ahmad, Rida Asrar, Ishtiaq Ahmed, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 3, pp. 474-475
Open Access | Times Cited: 4

HPV-specific antibodies in female genital tract secretions captured via first-void urine retain their neutralizing capacity
Laura Téblick, Marijana Lipovac, Freya Molenberghs, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 4

The Evolving Landscape of Cervical Cancer: Breakthroughs in Screening and Therapy Through Integrating Biotechnology and Artificial Intelligence
Raghu Aswathy, Sundaravadivelu Sumathi
Molecular Biotechnology (2024)
Closed Access | Times Cited: 4

Investigation of the Potency of KALA and REV Cell‐Penetrating Peptides for In Vitro/In Vivo Delivery of an HPV Multiepitope DNA Construct
Haleh Feyzyab, Alireza Milani, Elnaz Agi, et al.
Journal of Peptide Science (2025) Vol. 31, Iss. 3
Closed Access

Cancer Vaccines
Matjaž Zorko, Ülo Langel
Methods in pharmacology and toxicology (2025), pp. 213-229
Closed Access

HPV-51 or HPV-52 Infection Could Impair Sperm Quality in Infertile Patients: A Preliminary Study on Our Experience from North-Western Italy
Claudia Omes, Mariangela Rienzi, Roberta Rossini, et al.
Tropical Medicine and Infectious Disease (2025) Vol. 10, Iss. 2, pp. 36-36
Open Access

HPV vaccine hesitancy in the United States
Riya Joshi, Alexandra Kilinsky
Current Opinion in Pediatrics (2025) Vol. 37, Iss. 2, pp. 198-204
Closed Access

Preparation and evaluation of IgY against human papillomavirus
Weiguang Chen, Huanxin Xiao, Mingxia Lin, et al.
Journal of Virological Methods (2025), pp. 115115-115115
Closed Access

The Past, Present, and Future of Cervical Cancer Vaccines
Alexander C. Lien, Gertrude C. Johnson, Tianyun Guan, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 201-201
Open Access

Genotypic analysis of human papillomavirus in cervical exfoliated cells from women in Zigong
Xiaoyang Ma, Chuan Wu, Tao Wu, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access

Stability study of recombinant 9-valent human papillomavirus vaccine based on Escherichia coli expression system
Yuying Liu, Dan Chen, Li Zhao, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access

Quality of Life and Stress-Related Psychological Distress Among Patients with Cervical Cancer: A Cross-Sectional Analysis
Razvan Betea, Mirabela Dima, Veronica Daniela Chiriac
Diseases (2025) Vol. 13, Iss. 3, pp. 70-70
Open Access

Page 1 - Next Page

Scroll to top